High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 - Concepedia

Concepedia

Publication | Closed Access

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

331

Citations

29

References

2003

Year

Philip Poortmans, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche, Mars van’t Veer, Mads Hansen, Pierre Soubeyran, Martin Taphoorn, José Thomas, Martin J. van den Bent, M. Fickers,

Journal of Clinical Oncology

Abstract

MBVP followed by RT for PCNSL has a high response rate. However, the 10% toxic death rate during treatment in a multicenter setting underlines the need for highly specialized care.

References

	Year	Citations

Page 1